Simple biologically informed infammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69 A, Issue 2, 2014, Pages 165-173

  Varadhan, Ravi ^a   Yao, Wenliang ^a   Matteini, Amy ^a   Beamer, Brock A ^b   Xue, Qian Li ^a   Yang, Huanle ^a   Manwani, Bhavish ^a   Reiner, Alexander ^c   Jenny, Nancy ^d   Parekh, Neel ^a   Daniele Fallin, M ^e   Newman, Anne ^f   Bandeen Roche, Karen ^e   Tracy, Russell ^d   Ferrucci, Luigi ^g   Walston, Jeremy ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF PITTSBURGH   (United States)

^g NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Cytokine; Infammation; Mortality

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 18; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR 1;

AGED; AGING.; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; HUMAN; INFLAMMATION; LONGEVITY; MALE; METABOLISM; MORTALITY; PHYSIOLOGY; RISK FACTOR; VERY ELDERLY;

AGING.; CYTOKINE; INFLAMMATION; MORTALITY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-18; INTERLEUKIN-6; LONGEVITY; MALE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RISK FACTORS;

EID: 84896780657     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt023     Document Type: Article

References (39)

1. Singh T, Newman AB. Infammatory markers in population studies of aging. Ageing Res Rev. 2011;10:319-329.
2. Cesari M, Penninx BW, Pahor M, et al. Infammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59:242-248.
3. Tracy RP. Infammation in cardiovascular disease: cart, horse or both-revisited. Arterioscler Thromb Vasc Biol. 2002;22:1514-1515.
4. Huber SA, Sakkinen P, Conze D, Hardin N, Tracy R. Interleukin-6 exacerbates early atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 1999;19:2364-2367.
5. Hansson GK. Infammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
6. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
7. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of infammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999;353:1649-1652.
8. Davalos AR, Coppe JP, Campisi J, Desprez PY. Senescent cells as a source of infammatory factors for tumor progression. Cancer Metastasis Rev. 2010;29:273-283.
9. Puntmann VO, Taylor PC, Mayr M. Coupling vascular and myocardial infammatory injury into a common phenotype of cardiovascular dysfunction: systemic infammation and aging-A mini-review. Gerontology. 2011;57:295-303.
10. Pearson TA, Mensah GA, Alexander RW et al. Markers of infammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511.
11. Jenny NS, Yanez ND, Psaty BM, Kuller LH, Hirsch CH, Tracy RP. Infammation biomarkers and near-term death in older men. Am J Epidemiol. 2007;165:684-695.
12. Bandeen-Roche K, Walston JD, Huang Y, Semba RD, Ferrucci L. Measuring systemic infammatory regulation in older adults: evidence and utility. Rejuvenation Res. 2009;12:403-410.
13. Hanada T, Yoshimura A. Regulation of cytokine signaling and infammation. Cytokine Growth Factor Rev. 2002;13:413-421.
14. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol. 1995;5:278-285.
15. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1:263-276.
16. Fried LP. The epidemiology of frailty: the scope of the problem. In: Perry HM, Morley JE, Coe RM, eds. Aging, Musculoskeletal Disorders and Care of the Frail Elderly. New York: Springer; 1993:3-16.
17. Ferrucci L, Bandinelli S, Benvenuti E, et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc. 2000;48:1618-1625.
18. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-M156.
19. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem. 1997;43:52-58.
20. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;41:264-270.
21. Ferrucci L, Corsi A, Lauretani F, et al. The origins of age-related proinfammatory state. Blood. 2005;105:2294-2299.
22. Jolliffe IT. Principal Component Analysis. 2nd ed. New York: Springer; 2004.
23. Friedman J, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010;33:1-22.
24. Gerds TA, Kattan MW, Schumacher M, Yu C. Estimating a timedependent concordance index for survival prediction models with covariate dependent censoring. Statistics in Medicine. 2012; Published online in Wiley Online Library.
25. Heagerty PJ, Zheng Y. Survival model predictive accuracy and ROC curves. Biometrics. 2005;61:92-105.
26. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
27. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBM 3-900051-07-0. 2012; http://www. R-project.org/.
28. Wassel CL, Barrett-Connor E, Laughlin GA. Association of circulating C-reactive protein and interleukin-6 with longevity into the 80s and 90s: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2010;95:4748-4755.
29. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41:176-181.
30. Diniz BS, Teixeira AL, Ojopi EB, et al. Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer's disease. J Alzheimers Dis. 2010;22:1305-1311.
31. Safranow K, Dziedziejko V, Rzeuski R, et al. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease. Tissue Antigens. 2009;74:386-392.
32. Parsons PE, Matthay MA, Ware LB, Eisner MD; National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;288:L426-L431.
33. Churchman SM, Church LD, Savic S, et al. A novel TNFRSF1A splice mutation associated with increased nuclear factor kappaB (NF-kappaB) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS). Ann Rheum Dis. 2008;67:1589-1595.
34. Wijsman CA, Maier AB, De Craen AJ, Van Den Biggelaar AH, Westendorp RG. An unopposed proinfammatory response is beneficial for survival in the oldest old. Results of the Leiden 85-plus Study. J Gerontol A Biol Sci Med Sci. 2011;66:393-399.
35. Tsirpanlis G. Cellular senescence and infammation: a noteworthy link. Blood Purif. 2009;28:12-14.
36. Través PG, López-Fontal R, Cuadrado I, et al. Critical role of the death receptor pathway in the antitumoral effects induced by hispanolone derivatives. Oncogene. 2013;32:259-268.
37. Sorbara MT, Girardin SE. Mitochondrial ROS fuel the infammasome. Cell Res. 2011;21:558-560.
38. Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA. ELISA and multiplex technologies for cytokine measurement in infammation and aging research. J Gerontol A Biol Sci Med Sci. 2008;63:879-884.
39. Jylhä M, Paavilainen P, Lehtimäki T, et al. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci. 2007;62:1016-1021.